Skip to content

To study and evaluate the safety and effectiveness of Foot Plate System

A Prospective, Single Arm, Post Market Clinical Follow-up (PMCF) Study to Evaluate the Safety and Performance of Foot Plate System - PMCF

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065262
Enrollment
20
Registered
2024-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S920- Fracture of calcaneus Health Condition 2: S923- Fracture of metatarsal bone(s) Health Condition 3: S921- Fracture of talus

Interventions

Intervention1: Foot Plate System: The foot plate system is used for fixation of foot bones fracture. Duration of intervention will be 1 year. Control Intervention1: Not Applicable: Not Applicable

Sponsors

Auxein Medical Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient diagnosed with foot fractures, metatarsals fractures, osteotomies, nonunions and complex fractures of the calcaneus. 2. Both male and female above 18 (skeletally mature) to 75 years patients. 3. Patient is willing and able to give informed consent for participation in the study. 4. Patient willing and able to comply with post-operative study follow up.

Exclusion criteria

Exclusion criteria: 1. Any past or present evidence of infection of the treated joint. 2. Signs of any local inflammation. 3. Patient susceptibility to allergic reaction to the components of the alloy, the implant is manufactured from. 4. Mental illness or schizophrenic, which may cause patients to ignore the limitations and precautions of the implanted material, leading to implants fracture and complication. 5. Patients having inadequate tissue coverage over the operative site. 6. Severe osteopenia and/or osteoporosis, or in the presence of marked or rapid bone absorption, metabolic bone disease, cancer, or any other tumor ?like condition of the bone which may compromise fixation. 7. Patient who is pregnant or intends to become pregnant during the study. 8. Any patient unwilling to cooperate with the post ?operative instructions. 9. Any condition or anatomy that makes treatment with the Foot plate system infeasible.

Design outcomes

Primary

MeasureTime frame
Primary Outcome: Fracture healing [Time Frame: baseline, 1, 3, 6, 12 after surgery] evaluated by X-ray images ? Quality of foot movement by calculating Manchester foot questionnaire score [Time Frame: baseline, 1, 3, 6, 12 after surgery] ? Complications [Time Frame: baseline, at 1, 3, 6, 12 month post surgery] Timepoint: Baseline, 1, 3, 6 and 12 months after surgery

Secondary

MeasureTime frame
Pain on the affected region using VAS(Visual Analog Scale) Timepoint: Baseline, 1, 3, 6 and 12 months after surgery

Countries

India

Contacts

Public ContactMr Gaurav Luthra

Auxein Medical Pvt. Ltd.

clinical2@auxeinmedical.com7419066141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026